Northwell Health Expands Testing to Aid COVID-19 Recovery

As part of a complex plan aimed at restarting the economy, Northwell Health is working with public health officials to provide antibody testing to first-responders across Long Island and Westchester County, MTA transit workers as well as low-income and predominantly minority communities throughout the region to help identify and deliver care to those at highest risk of COVID-19.

Police, fire and EMS workers on the front lines of the coronavirus pandemic are being offered free antibody testing through the Nassau and Suffolk departments of health. Northwell has already processed more than 2,500 antibody tests from Long Island first responders, and will begin offering testing to first-responders in Westchester County today (May 12). First responders can book appointments through each county’s department of health. In addition, Northwell Health-GoHealth Urgent Care is finalizing an agreement with the Metropolitan Transportation Authority to provide antibody testing to its transit workers. In mid-April, the MTA joined forces with Northwell Health-GoHealth to provide COVID-19 diagnostic testing to symptomatic transit workers at its 52 urgent care facilities throughout the metropolitan area.

“It’s imperative that we provide this critical testing to our front line heroes and the local communities that have been hardest hit by this,” said Dwayne Breining, MD, executive director, Northwell Health Labs. “We now have the capacity to handle thousands of antibody tests per day. This testing provides quick and reliable testing results which are crucial to understanding how the virus has spread and will be critical to opening up our economy.”

Antibodies are proteins that help fight off infections. Antibody blood tests show if people have had a previous infection with COVID-19. It’s unclear if those antibodies can protect people from getting infected again, but many who contract the virus had mild or no symptoms, so the test confirms whether they had the virus previously and also helps show the prevalence of COVID-19 within various communities.

In response to the higher prevalence of COVID-19 cases in low-income and minority communities, Northwell and the state Department of Health will begin offering antibody and diagnostic testing this Wednesday (May 13) at 24 churches in Brooklyn, the Bronx, Queens, Manhattan, Staten Island, and Nassau and Westchester counties.

The free tests will be offered by appointment only this Wednesday through Sunday (May 17), and the following week from May 20-24. Diagnostic testing will be offered on different days from antibody testing to limit the exposure of patient populations. To find a location and make an appointment, call 833-4CARENY.

“One way we can protect our most vulnerable communities is by making testing more easily accessible in the communities that need them most,” said Michael Dowling, president and CEO of Northwell Health. “The quicker we can expand access to testing in low-income communities, the quicker people can be diagnosed and isolated from family members and friends and reduce the risk of spreading the virus.”

Recently released data by New York State found a greater infection rate in communities of color, including a correlation between newly admitted patients hospitalized for COVID-19. Data shows that 20 of the 21 zip codes driving current patient admissions have greater than average African American and Latino populations. Two of the most impacted communities in Brooklyn and the Bronx revealed as communities of color are also lower-income and have a greater percentage of COVID-19 hospitalization and infections than New York City overall.

Besides the MTA, Northwell Health-GoHealth Urgent Care is also providing access to testing for the New York State Police, New York City Police Department and New York City Fire Department. In addition, antibody testing will be provided to New York Racing Association employees at Belmont Racetrack.

 

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."